PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-10.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-21.50%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.50%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-35.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-34.91%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-34.22%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-7.58%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-7.72%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
7.77%
Dividend growth of 7.77% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
2.36%
OCF growth under 50% of AR's 7.56%. Michael Burry might suspect questionable revenue recognition or rising costs.
-43.26%
Negative FCF growth while AR is at 15.38%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
141.25%
10Y revenue/share CAGR at 50-75% of AR's 226.56%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
294.39%
5Y revenue/share CAGR above 1.5x AR's 76.73%. David Dodd would look for consistent product or market expansions fueling outperformance.
182.48%
Positive 3Y CAGR while AR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
535.10%
5Y OCF/share CAGR above 1.5x AR's 266.41%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
159.28%
Positive 3Y OCF/share CAGR while AR is negative. John Neff might see a big short-term edge in operational efficiency.
268.40%
Net income/share CAGR 1.25-1.5x AR's 196.15%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
833.89%
5Y net income/share CAGR above 1.5x AR's 129.17%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
194.88%
Positive short-term CAGR while AR is negative. John Neff would see a clear advantage in near-term profit trajectory.
441.52%
10Y equity/share CAGR above 1.5x AR's 24.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
202.11%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
103.73%
3Y equity/share CAGR above 1.5x AR's 31.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
355.97%
Dividend/share CAGR of 355.97% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
314.57%
3Y dividend/share CAGR of 314.57% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-3.46%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
12.45%
Inventory growth of 12.45% while AR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
4.76%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
16.95%
BV/share growth above 1.5x AR's 1.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.17%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-22.95%
We cut SG&A while AR invests at 24.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.